Evidence map›Paper›PMID 36369589›Full record

ArticlePharmaceutical research2022

Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.

Sepideh Izadi, Asma Moslehi, Hadiseh Kheiry, Fariba Karoon Kiani, Armin Ahmadi, Ali Masjedi, Sepideh Ghani, Behnam Rafiee, Vahid Karpisheh, Farnaz Hajizadeh and 7 more

RetractedOpen access · bronzeAbstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 3 countries.

Sepideh IzadiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Asma MoslehiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hadiseh KheiryDivision of Genetics, Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran.
Fariba Karoon KianiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Armin AhmadiDepartment of Chemical and Materials Engineering, The University of Alabama in Huntsville, Huntsville, Alabama, 35899, USA.
Ali MasjediDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sepideh GhaniStudent Research Committee, Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Behnam RafieeDepartment of Biology, Faculty of Basic Science, Payame Noor University, Tehran, Iran.
Vahid KarpishehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Farnaz HajizadehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Fatemeh AtyabiNanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Akram AssaliNanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Farnaz Sadat Mirzazadeh TekieDepartment of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Afshin NamdarDepartment of Oncology, Cross Cancer Institute, The University of Alberta, Edmonton, Alberta, Canada.
Ghasem GhalamfarsaCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
Mozhdeh SojoodiDivision of Surgical Oncology, Massachusetts General Hospital Cancer Center and, Harvard Medical School, Boston, USA. msojoodi@mgh.harvard.edu.
Farhad Jadidi-NiaraghImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. jadidif@tbzmed.ac.ir.ORCID http://orcid.org/0000-0002-4641-882X
Tabriz University of Medical Sciences · IRTehran University of Medical Sciences · IRHarvard University · USPayame Noor University · IRShahid Beheshti University of Medical Sciences · IRUniversity of Alabama in Huntsville · USUniversity of Alberta · CAUniversity of Isfahan · IRYasuj University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36369589
OpenAlexW4308834752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.